Immediate Impact
1 from Science/Nature 5 standout
Citing Papers
Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life
2025 Standout
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2025 Standout
Works of Maxim Kots being referenced
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Maxim Kots | 143 | 134 | 11 | 11 | 5 | 147 | |
| Eric Bateman | 127 | 113 | 14 | 7 | 4 | 177 | |
| E. D. Bateman | 88 | 73 | 10 | 7 | 5 | 115 | |
| Thomas Keast | 108 | 160 | 11 | 5 | 9 | 191 | |
| Judy E. Harrison | 170 | 135 | 57 | 6 | 6 | 198 | |
| Ove Hansen | 182 | 187 | 18 | 14 | 5 | 231 | |
| Steven Kelsen | 44 | 63 | 6 | 7 | 4 | 164 | |
| Nikolaos Lazarinis | 94 | 64 | 33 | 49 | 6 | 167 | |
| Henry Matallana | 81 | 43 | 3 | 27 | 3 | 124 | |
| Keith Edwards | 64 | 71 | 2 | 12 | 7 | 134 | |
| Friedrich Horak | 202 | 139 | 84 | 8 | 7 | 250 |
All Works
Login with ORCID to disown or claim papers
Loading papers...